$SLQT

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

Original reporting
Published Sep 1, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote (SLQT) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SLQTBullishHigh
01

Why it matters

The company delivered a modest profit improvement and raised cash flow expectations, signaling operational discipline.

02

Market read

First release of SelectQuote's FY2026 earnings and FY2027 guidance, providing actionable data for traders.

03

What to watch

Potential regulatory changes to Medicare Advantage and drug pricing could affect future performance.

Relevance 8/10Novelty 8/10Timing: pre‑market

Background

SelectQuote (SLQT) held its FY2026 earnings call, presenting results and FY2027 outlook.

Company-level read

Ticker impact

$SLQTBullishHigh confidence
Context

SelectQuote reported FY2026 revenue of $1.6B and issued FY2027 revenue guidance of $1.35‑$1.45B, plus adjusted EBITDA and cash flow guidance.

Expected impact

Potential upside of 5‑10% on the day of release, with volatility on guidance details.

Evidence & confidence

First disclosure of full-year results and forward guidance provides fresh material for pricing.

Market effects

Healthcare services and Medicare Advantage segments may see broader sentiment shifts.

U.S. insurance and health‑care stocks could react to SelectQuote's guidance.

Limited; primarily U.S. market impact.

Counterpoint

If guidance falls short of consensus expectations, the stock could face a sharp sell‑off.

Key entities

  • Timothy Danker

    CEO of SelectQuote

  • Ryan Clement

    CFO of SelectQuote

Related articles

$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges:

$NUEMedAI 8/10

Nucor Announces Guidance for the Third Quarter of 2026 Earnings

Nucor (NYSE: NUE) expects Q3 2026 earnings of $5.55-$5.65 per share, up from Q2 2026's $5.04 and Q3 2025's $2.63. Growth is anticipated in steel mills and products segments, while raw materials may decline. The company repurchased 2.03M shares at $247.04 each, returning $1.36B to shareholders year-to-date.